Section Phar 7.05 - Label requirements(1) This section does not apply to institutional pharmacies as defined in s. 7.50(3)(2) All prescribed drugs or devices shall have a label attached to the container disclosing all of the following: (a) Identification of the patient by one of the following:1. Except as provided in subds. 2. to 5., the first and last name of the patient.2. For an antimicrobial drug dispensed under s. 450.11(1g), Stats., the first and last name of the patient, if known, or the words, "expedited partner therapy" or the letters "EPT".3. For an opioid antagonist when delivered under s. 450.11(1i), Stats., the first and last name of the person to whom the opioid antagonist is delivered.4. For an epinephrine auto-injector prescribed under s. 118.2925(3) or 255.07(2), Stats., the name of the school, authorized entity, or other person specified under s. 255.07(3), Stats.5. If the patient is an animal, the last name of the owner, name of the animal and animal species.(b) Symptom or purpose for which the drug is being prescribed if the prescription order specifies the symptom or purpose.(c) Name and strength of the prescribed drug product or device dispensed, unless the prescribing practitioner requests omission of the name and strength of the drug product or device.(d) The date for which the medication shall not be used after.(e) Pharmacy name, address and telephone number.(g) Date the prescription was filled.(h) Prescription order number.(j) Number of refills or quantity remaining. (k) Directions for use of the prescribed drug or device as contained in the prescription order.(3) A label for prescribed drugs or devices may include the following: (a) Symptom or purpose for which the drug is being prescribed if requested by the patient.(b) Both the generic name of the drug product equivalent and the brand name specified in the prescription order may be listed on the label if the brand name is listed on the prescription and the drug product equivalent is dispensed, unless the prescribing practitioner requests that the brand name be omitted from the label.(c) Written or graphic product descriptions.(d) Any cautions or other provisions.(4) Subsection (2) does not apply to complimentary samples of drug products or devices dispensed in original packaging by a practitioner to his or her patients.Wis. Admin. Code Pharmacy Examining Board Phar 7.05
Adopted by, CR 19-145: cr. Register December 2020 No. 780, eff. 1/1/2021